Total Revenue: $86.4 million in Q2 2024; pro forma revenue was $102.6 million. GAAP Gross Margin: 80% in Q2 2024. Non-GAAP Gross Margin: 81% in Q2 2024; pro forma gross margin was 82%. International ...
Therefore, we continue to provide pro forma results, which add to the non-GAAP results, the pre-order sales and related expenses. We believe that the pro forma results better reflect our business ...
As of 11:35:12 AM GMT+1. Market Open. InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences ...
On Friday, Baird reaffirmed its positive stance on InMode Ltd . (NASDAQ:INMD), maintaining an Outperform rating and a $22.00 price target. InMode, known for its medical technology for aesthetic ...
Elevated interest rates continue to hurt InMode’s revenue, especially as lease package interest rates haven't fallen yet. Still, future rate cuts could release pent-up demand. InMode continues to buy ...
YOKNEAM, Israel, April 14, 2025 /PRNewswire/ -- InMode Ltd. (INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results